Read + Share
Amedeo Smart
Independent Medical Education
Basu A, Winn AN, Johnson KM, Jiao B, et al. Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Ann Intern Med 2024;177:155-164.PMID: 38252942
Email
LinkedIn
Facebook
Twitter
Privacy Policy